Bio adhesives are polymers that have an abilities to adhere to a biological tissue for an extended period of time. There are two major types of bio adhesive, plant based and animal based bio adhesive. Bio adhesives have been investigated as potential drug delivery systems for oral administration. There are various medicine where bio adhesive are used such as nasal spray ear drops, eye drops, ointment, hydrogel, nano sphere suspension, insufflation, and microsphere tablet. Moreover, over the last decade bio adhesives is considering one of the best drugs for the treatment of oral administration
The increase in patient population of dental and ophthalmic diseases is increasing the demand for bio adhesive in global market. According to report published by the World Health Organization (WHO), in 2017, number of population suffering with vision impairment could triple due to ageing population growth, and it is projected that by 2050 around 115 million people will get blind and by 2020. Report suggest that around 19 million children below age 15 years are vision impaired, including 12 million children who have a vision impairment due to refractive error and 1.4 million have irreversible blindness.
Increasing prevalence of diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for research and development, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period 2017-2027.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1233 .
Bioadhesive Alliance Inc.(U.S), Camurus (Sweden), Henkel Corporation (U.S), Ashland Inc. (U.S.), 3M Company (U.S.), Adhesives Research (U.S.), Yparex B.V. (the Netherlands), EcoSynthetix Inc. (Canada), Adhbio (Spain) are some of the prominent players at the forefront of competition in the Global Bio adhesive Market and are profiled in MRFR Analysis.
Global Bio Adhesive Market – Competitive Analysis
April, 2016- Camurus Company had signed agreement with R-PHARM U.S. (Princeton, NJ) and had granted the exclusive license and distribution rights for episil oral liquid in the U.S. R-PHARM US was founded in 2014 with the goal of acquiring and commercializing products that help patients suffering from cancer and immunology conditions. As per company reports, R-PHARM US is a subsidiary of R-PHARM JSC, global pharmaceutical business with 2015 sales of ~$1.5B, primarily in Russia and Eastern Europe. R-PHARM’s portfolio includes IXEMPRA, a chemotherapy agent approved for metastatic breast cancer, and a pipeline that includes molecules being developed for immunology and oncology indications. The most advanced pipeline asset is olokizumab, a Phase 3-ready IL-6 being developed for rheumatoid arthritis and other immunologic conditions. And episil oral liquid, is a unique and effective treatment for the pain of oral mucositis, a treatment-limiting side effect of cancer therapies, as well as other oral lesions. As per company reports, Camurus’s technology FluidCrystal, episil is administered as a lipid-based liquid that spreads on the intra-oral mucosal surfaces and transforms to a strongly bioadhesive film that mechanically protects the sensitized and sore epithelium of the oral cavity.
Browse complete report at https://www.marketresearchfuture.com/reports/bio-adhesive-market-1233 .
Europe dominate the global bio adhesive market owing to the presence of manufactures and increasing government support for research & development. Moreover increasing demand of bio adhesive globally leads the manufacturer increase the export of these products and capture highest market share in global market.
The Americas holds the second largest share of the global bio adhesive market as result of increasing focus of various government agencies on the treatment of rare diseases such as ophthalmic and dental. Moreover, the growing public awareness about bio adhesive likely to boost the Americas market.
Asia Pacific is the fastest growing bio adhesive market across the globe. Rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in this region for the forecast period. Moreover, the growth of market is attributed to increasing need for the sophisticated healthcare facilities and increasing demand for various new treatment methods. For instance countries such as India and China are the major contributor for the growth market.
The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities.
Market Research Future
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312